Solomon, E. A. http://orcid.org/0000-0003-0541-7588
Kragel, J. E.
Gross, R.
Lega, B.
Sperling, M. R.
Worrell, G.
Sheth, S. A.
Zaghloul, K. A. http://orcid.org/0000-0001-8575-3578
Jobst, B. C.
Stein, J. M.
Das, S.
Gorniak, R.
Inman, C. S.
Seger, S.
Rizzuto, D. S.
Kahana, M. J.
Funding for this research was provided by:
DOD | Defense Advanced Research Projects Agency (N66001-14-2-4032)
U.S. Department of Health & Human Services | National Institutes of Health (MH55687, T32NS091006)
Article History
Received: 5 June 2018
Accepted: 1 October 2018
First Online: 25 October 2018
Competing interests
: M.J.K. and D.S.R. have started a company, Nia Therapeutics, LLC (“Nia”), intended to develop and commercialize brain stimulation therapies for memory restoration. Each of them holds >5% equity interest in Nia. R. Gross serves as a consultant to Medtronic, which is a subcontractor on the RAM project. R. Gross receives compensation for these services. The terms of this arrangement have been reviewed and approved by Emory University in accordance with its conflict of interest policies. The remaining authors declare no competing interests.